September 19, 2020

Volume X, Number 263

September 18, 2020

Subscribe to Latest Legal News and Analysis

September 17, 2020

Subscribe to Latest Legal News and Analysis

September 16, 2020

Subscribe to Latest Legal News and Analysis

Divisional Practice in the BRICs and other Countries – Part 9 of a 9-Part Series: A Comprehensive Summary

In this last post in the series, we at the BRIC Wall are pleased to provide a table summarizing the key aspects of divisional practice in the 8 countries surveyed.  We hope our readers have found this series to be education and informative. 

Divisional Summary Table:  FINALDIVISONALTABLE 2

This is Part 9 of a nine-part series examining divisional practice in the BRIC as well as several non-BRIC countries.

To view Part 1 (Divisional Practice in Mexico), click here.

To view Part 2 (Divisional Practice in Brazil), click here.

To view Part 3 (Divisional Practice in the United States), click here.

To view Part 4 (Divisional Practice in India), click here.

To view Part 5 (Divisional Practice in Russia), click here.

To view Part 6 (Divisional Practice in China), click here.

To view Part 7 (Divisional Practice in Canada), click here.

To view Part 8 (Divisional Practice in Europe), click here.

©2020 MICHAEL BEST & FRIEDRICH LLPNational Law Review, Volume IV, Number 92


About this Author

Lisa Mueller, Michael Best, Patent application Attorney, intellectual property lawyer,
Partner, Industry Group Chair, Life Sciences

Lisa provides strategic counsel on complex patent issues to clients in the pharmaceutical, biopharmaceutical, biotechnology and chemistry sectors. She brings an in-depth knowledge and extensive experience to her work advising clients on patent protection, freedom to operate and invalidity of blockbuster drugs they aim to produce and distribute.

Lisa’s advice on the full spectrum of global intellectual property portfolio management includes patent prosecution, opposition and other post-grant proceedings